इस एपिसोड के बारे में
In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Dr R Ananthanarayanan, global biopharma and healthcare executive and former Chief Executive Officer (CEO) of Teva's active pharmaceutical ingredients business.
Ananth, as he is known in the industry, has more than four decades of experience across pharma and wider healthcare. In this conversation, he explains why he treats ambiguity as an opportunity and starts with the problem statement, a clear description of the real problem before any solution is chosen.
In this episode, Ananth shares how a rejected sales application, and the advice to go back to research, led him to add commercial skills to his science background, and in doing so, building 360-degree leadership. He also covers leading across cultures, staying calm under pressure, cautious optimism and why failing fast in life sciences helps teams succeed sooner.
Key Takeaways
· Learn why defining the problem statement comes first. Ambiguity holds the opportunity, so find the true problem before choosing a solution.
· Understand how to tell uncertainty from paralysis. Get comfortable saying you do not know yet, while keeping enough clarity to take the next intelligent step.
· Apply the rule to slow down to understand, then speed up to execute. Experienced leaders can mistake a new problem for an old one, so pause to understand the problem, not to delay the decision.
· Discover how failing fast helps teams succeed sooner, and why teams need the freedom to fail within guardrails.
· Gain a working view of cautious optimism: stay optimistic about the possibilities, stay cautious about the assumptions and avoid false confidence.
· Identify how to stay calm under pressure by separating the emotional response from the decision.
· Explore how commercial skills added to a scientific background build 360-degree leadership, without becoming less technical.
· Take away Ananth's approach to leading across cultures: keep principles consistent, adapt style and listen for what isn’t being said.
· Uncover why titles do not always equate ti leadership, and why building depth first, then breadth, supports a career.
Snippets
· "Ambiguity isn't always the absence of opportunity. Sometimes ambiguity itself is the opportunity."
· "Experienced leaders can become victims of their own experience. ... So slow down to understand, speed up to execute."
· "I didn't become commercial by becoming less technical. ... I became commercial by adding another dimension to my technical education."
Timestamps & Topics
The following timestamps are approximations:
· [01:49] – Active Ingredients: Curiosity, courage and humility
· [16:08] – Rejection: Told he was not qualified for a sales role
· [20:27] – Ambiguity: Why defining the problem statement comes first
· [28:03] – Commercial Skills: Adding breadth to scientific depth
· [38:49] – Global Leadership: Principles stay fixed while style adapts
· [45:55] – Cautious Optimism: Confidence without ignoring risk
· [57:44] – Future Leadership: Building organisations that keep learning
Resources
· Follow Dr R Ananthanarayanan on LinkedIn: https://www.linkedin.com/in/ananth123/
· Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/
Don't Miss an Episode
Sign up to the Active Ingredients podcast at www.activeingredients.fraserdove.com.
Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Amazon, Spotify, YouTube and other leading podcast platforms.
Loved this episode?
Share it with your friends, family, or your peers!
